Cart
sales@molnova.com
6-TAMRA
CAS No. 91809-67-5
6-TAMRA( 6-Carboxytetramethylrhodamine )
Catalog No. M24966 CAS No. 91809-67-5
6-TAMRA has been a widely used fluorophore for preparing bioconjugates, especially fluorescent antibody and avidin derivatives used in immunochemistry.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 39 | In Stock |
|
| 25MG | 70 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name6-TAMRA
-
NoteResearch use only, not for human use.
-
Brief Description6-TAMRA has been a widely used fluorophore for preparing bioconjugates, especially fluorescent antibody and avidin derivatives used in immunochemistry.
-
Description6-TAMRA has been a widely used fluorophore for preparing bioconjugates, especially fluorescent antibody and avidin derivatives used in immunochemistry.
-
In Vitro——
-
In Vivo——
-
Synonyms6-Carboxytetramethylrhodamine
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number91809-67-5
-
Formula Weight430.45
-
Molecular FormulaC25H22N2O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:2.86 mg/mL (6.64 mM; Need ultrasonic)
-
SMILESCN(C1=CC2=[O+]C3=C(C=CC(N(C)C)=C3)C(C4=CC(C([O-])=O)=CC=C4C(O)=O)=C2C=C1)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Amlodipine aspartic ...
Amlodipine aspartic acid is a calcium channel blocker with antihypertensive and antianginal properties. Amlodipine aspartic acid impurity is the impurity of Amlodipine aspartic acid.
-
(Z)-non-6-en-1-ol
(Z)-non-6-en-1-ol (cis-6-Nonen-1-ol) is a volatile substance contained in melons and can be used to detect the freshness of melons and fruits.
-
Bintrafusp alfa
Bintrafusp alfa (M7824) is a bifunctional fusion protein consisting of the extracellular structural domain of TGF-βRII (a TGF-β “trap”) fused to a monoclonal antibody against human immunoglobulin G1 fused to programmed death ligand 1 (PD-L1).
